Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
About Us
Contact
Services
Institutions
Market Impact Report
Sign up
Log in
Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
About Us
Contact
Services
Institutions
Market Impact Report
Log in
Sign up
×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks
Home
TORC
News
TORC –
restorbio
(US:NASDAQ)
DELAYED
$
usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TORC
SPY
QQQ
SPX
News
Earning News
Analyst Actions
SEC Filings
Date
Time
Symbol
Headline
Impact
9/24
08:00 am
torc
resTORbio to Present at 2018 Cantor Fitzgerald Global Healthcare Conference
Low
9/18
08:55 am
torc
ResTORbio appoints Meredith Manning as Chief Commercial Officer [Seeking Alpha]
Low
9/18
08:00 am
torc
resTORbio Appoints Meredith Manning as Chief Commercial Officer
Low
8/29
11:45 am
torc
resTORbio, Inc. (NASDAQ: TORC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.
Low
8/29
08:00 am
torc
resTORbio to Present at Wells Fargo 2018 Healthcare Conference
Low
8/15
08:00 am
torc
resTORbio Appoints Jeffrey Chodakewitz, M.D., to its Board of Directors
Medium
8/9
08:00 am
torc
resTORbio Reports Second Quarter 2018 Financial Results
Medium
8/1
10:39 am
torc
resTORbio, Inc. (NASDAQ: TORC) had its "in-line" rating re-affirmed by analysts at Evercore ISI.
Low
7/31
10:11 pm
torc
resTORbio, Inc. (NASDAQ: TORC) was downgraded by analysts at Evercore ISI to an "outperform" rating.
Medium
7/31
11:43 am
torc
resTORbio, Inc. (NASDAQ: TORC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $16.00 price target on the stock.
Medium
7/30
07:00 am
torc
resTORbio to Present at the Canaccord Genuity 38th Annual Growth Conference
Medium
7/28
10:01 am
torc
Your Daily Pharma Scoop: ResTORbio Skyrockets, Corbus Moves Ahead, GSK Halted [Seeking Alpha]
Medium
7/25
12:40 pm
torc
Why resTORbio, Inc. Stock Skyrocketed Today [The Motley Fool]
Low
7/25
09:45 am
torc
ResTORbio's stocks rockets on positive trial results, just as post-IPO lock up expires [MarketWatch]
High
7/25
07:47 am
torc
ResTORbio's RTB101 successful in mid-stage study; shares up 144% premarket [Seeking Alpha]
High
7/25
07:00 am
torc
resTORbio Announces Positive Topline Results in Phase 2b Trial of RTB101
High
7/18
10:01 pm
torc
Recent Biotech IPO ResTORbio (TORC) Is Ground Zero For Something Huge [Seeking Alpha]
Low
7/13
02:30 pm
torc
ResTORbio - Leading The Charge Against Aging Related Diseases [Seeking Alpha]
Low
7/13
06:01 am
torc
Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters [Seeking Alpha]
Low
7/11
03:13 pm
torc
ResTORbio's RTB101 shows treatment benefit in mid-stage study; shares up 9% [Seeking Alpha]
Low
7/11
02:07 pm
torc
resTORbio Announces Science Translational Medicine Publication of Phase 2a Data Showing Improvement in Immune Function and Decreased Infection Rates in People Aged 65 Years and Older
High
Live Event:
Click Here To Register For The Live Online Workshop
Latest Posts
How to Win Capital and Influence Markets: Analysts Point To Profits (Even When They're Wrong)
Weekly Market Roundup + Top Performer: Cannabis, Trade Deals, and A Brand-New Sector
The Paradox at the Heart of Today's Stock Market
Measuring the News: A Look at NewsQuantified's Stock Impact Reports
NQ Founder to Appear on Expert Investing Panel | Sign Up for Live Event